[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Arhdan9 Arh Dan

Arh Dan posts on X about $tnxp, $225m, $231m, stocks the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX -XX%
• X Month XXXXXX +80%
• X Months XXXXXXX +15%
• X Year XXXXXXX +1,413%

Mentions: X #

• X Week XX -XX%
• X Month XXX +80%
• X Months XXX +27%
• X Year XXX +2,334%

Followers: XXX #

• X Week XXX -XXXX%
• X Month XXX +0.63%
• X Months XXX +20%
• X Year XXX +105%

CreatorRank: undefined #

Social Influence

Social category influence stocks XXXX% finance XXXX% technology brands XXXX%

Social topic influence $tnxp #6, $225m 3.85%, $231m 3.85%, stocks 3.85%, wallstreetbets 3.85%, target 3.85%, blockbuster 3.85%, novartis 3.85%, sanofi 3.85%, $abbv XXXX%

Top accounts mentioned or mentioned by @cnbc @tony54162200 @jimcramer @elonmusk @benzinga @stocktwits @michaeljburry @reformedbroker @bespokeinvest @tonixpharma @sethlederman @hodlmagoo @wallstreetmav @wallstreetbets @wallstreetapes @wsj @jnjnews @roche @pfizer @abbvie

Top assets mentioned Novartis AG (NVS) Sanofi (SNY) AbbVie Inc (ABBV) NVIDIA Corp. (NVDA) Advanced Micro Devices (AMD) Cream (CRM) UnitedHealth Group (UNH)

Top Social Posts

Top posts by engagements in the last XX hours

"$TNXP Which of these big pharma companies will acquire $TNXP within a year"
X Link 2025-11-27T14:58Z XXX followers, 1216 engagements

"$TNXP Interesting article attached below brackets. Background information: Potential blockbuster drug Tonmay launched. Cash $225m. MC $231m #Stocks @WallStreetMav @wallstreetbets @WallStreetApes @CNBC @WSJ #10bagger"
X Link 2025-12-06T16:26Z XXX followers, 1082 engagements

"$TNXP $1000 target price: Multiple blockbuster drugs in the making: Tonmya scheduled to launch in October TNX-4800 P2/3 for Lyme disease launches soon TNX-102 SL for Acute Stress Disorder P2 enrolling TNX-102 SL for major depression disorder P2 launches by end of '25 etc"
X Link 2025-09-18T21:29Z XXX followers, 6141 engagements

"@JNJNews @Roche @pfizer @abbvie @EliLillyandCo @Novartis @sanofi @bmsnews @AstraZeneca @GSK @BayerPharma @novonordisk @Amgen @TakedaPharma @Boehringer @tevapharm @AstellasUS@biogen @OtsukaUS @AlbertBourla @VasNarasimhan"
X Link 2025-11-27T15:00Z XXX followers, XXX engagements

"@CscottLawyer @theRealKiyosaki $TNXP Never waver on its prospect at least #10bagger. 10m patients 2.7m actively seeking new treatment Tonmya is the first drug approved in XX years and it's non opioid drug. May still be some dilution b4 it becomes profitable some times next year Price trading at cash value"
X Link 2025-12-04T16:42Z XXX followers, XXX engagements

"@jimcramer Sold twice taking profit on $NVDA $AMD. Added on $CRM $UNH which will be X of best in "26 $TNXP $NWBO are #10bagger the former launched non-opioid drug for 10m patients while the latter may receive 1st regulatory approval any day. The beauty is all have been hated for years"
X Link 2025-12-09T00:37Z XXX followers, XXX engagements